Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 95591532 | 9559153 | 2 | F | 20160712 | 20130927 | 20160713 | EXP | TW-BRISTOL-MYERS SQUIBB COMPANY-19401728 | BRISTOL MYERS SQUIBB | 67.00 | YR | F | Y | 0.00000 | 20160713 | OT | TW | TW |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 95591532 | 9559153 | 1 | PS | WARFARIN SODIUM. | WARFARIN SODIUM | 1 | Unknown | 2.5 MG, QD | U | 9218 | 2.5 | MG | QD | ||||||
| 95591532 | 9559153 | 2 | I | MOXIFLOXACIN HCL | MOXIFLOXACIN | 1 | Unknown | 400 MG, QD | U | 0 | 400 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 95591532 | 9559153 | 1 | Anticoagulant therapy |
| 95591532 | 9559153 | 2 | Pneumonia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 95591532 | 9559153 | HO |
| 95591532 | 9559153 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 95591532 | 9559153 | Abdominal wall haematoma | |
| 95591532 | 9559153 | Drug interaction | |
| 95591532 | 9559153 | Peritoneal haemorrhage |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |